Durvalumab after chemoradiotherapy in stage III NSCLC: 4-year survival update from the phase III PACIFIC trial


Faivre-Finn C., Vicente D., Kurata T., Planchard D., Paz-Ares L., Vansteenkiste J. F., ...More

ESMO Virtual Congress, ELECTR NETWORK, 19 September - 18 October 2020, vol.31

  • Publication Type: Conference Paper / Summary Text
  • Volume: 31
  • Doi Number: 10.1016/j.annonc.2020.08.2281
  • Country: ELECTR NETWORK
  • Istanbul University Affiliated: No